Four-Component Recombinant Protein-Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy.
JAMA Netw Open
; 6(8): e2329678, 2023 08 01.
Article
in En
| MEDLINE
| ID: mdl-37594762
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
4_TD
Database:
MEDLINE
Main subject:
Meningococcal Vaccines
/
Meningococcal Infections
Type of study:
Etiology_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
/
Infant
Country/Region as subject:
Europa
Language:
En
Journal:
JAMA Netw Open
Year:
2023
Document type:
Article